Advantage Trust Company’s Pfizer PFE Stock Holding History

Advantage Trust Company’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$129K	Buy	5,353 +300	+6%	+$7.85K	0.05%	73
2026 Q1	$142K	Sell	5,053 -597	-11%	-$15.9K	0.06%	49
2025 Q4	$141K	Sell	5,650 -300	-5%	-$7.57K	0.06%	48
2025 Q3	$152K	Hold	5,950	–	–	0.07%	69
2025 Q2	$144K	Hold	5,950	–	–	0.07%	68
2025 Q1	$151K	Hold	5,950	–	–	0.09%	51
2024 Q4	$158K	Hold	5,950	–	–	0.09%	50
2024 Q3	$172K	Hold	5,950	–	–	0.12%	43
2024 Q2	$166K	Hold	5,950	–	–	0.12%	48
2024 Q1	$165K	Hold	5,950	–	–	0.12%	49
2023 Q4	$171K	Buy	+5,950	New	+$180K	0.13%	46

Other funds holding PFE

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Welch Group Birmingham, Alabama $2.93B AUM 27.62% 1-Year Est. Return

Advantage Trust Company's PFE Position: Q2 2026 in Review

Advantage Trust Company increased its Pfizer (PFE) stake by 5.9% in Q2 2026, buying an estimated $7.85K and bringing the position to 5,353 shares worth $129K. The position accounts for 0.05% of the portfolio, ranked #73.

Advantage Trust Company first reported a position in PFE in Q4 2023 and has held it in 11 quarters since. The position peaked at $172K in Q3 2024. 901 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Advantage Trust Company held 5,353 shares of Pfizer worth $129K as of Q2 2026.
Advantage Trust Company bought 300 Pfizer shares in Q2 2026, an estimated $7.85K.
Pfizer made up 0.05% of Advantage Trust Company's portfolio in Q2 2026, its #73 holding.
Advantage Trust Company first reported a position in Pfizer in Q4 2023 and has held it in 11 quarters since.
Advantage Trust Company's Pfizer position peaked at $172K in Q3 2024.
901 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Advantage Trust Company's 13F filing for Q2 2026, filed 17 Jul 2026.